Visitors Now:
Total Visits:
Total Stories:
Profile image
By dailynewsforyou
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Beat Obamacare with These Biotech ETFs

Monday, April 22, 2013 21:20
% of readers think this story is Fact. Add your two cents.
Get FREE private and secure Email and Messaging click now!

(Before It's News)

Many investors are worried about the effects of Obamacare on their health insurance, quality of medical care and the economy. But one health care sub-sector that is booming despite the proposed changes is the biotechnology industry.

Biotech has always been a niche piece of many growth investors’ portfolios, but with the blossoming of the ETF industry you now have access to these cutting edge companies in just a single fund. So far this year biotech is one of the leading sectors in terms of absolute performance which is why it’s a perfect way to diversify your portfolio in a sector that continues to add alpha.

Large Cap Biotech

The largest ETF in the biotech sector is the iShares Biotech ETF (IBB). The fund currently has $2.88 billion in total assets spread among 120 companies with an expense ratio of 0.48%. The top three holdings in IBB include: Regeneron Pharmaceuticals (REGN), Gilead Sciences Inc. (GILD), and Amgen Inc. (AMGN). Together these three companies make up approximately 26% of the fund.

Read More: http://economicrisis.com/beat-obamacare-with-these-biotech-etfs/5585

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story
Share This Story:
Print this story
Email this story
GET ALERTS:

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.